These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19119151)

  • 1. Opportunities and challenges in the study of pulmonary arterial hypertension.
    McLaughlin V; Strange C
    Am J Respir Crit Care Med; 2009 Jan; 179(2):91-2. PubMed ID: 19119151
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary hypertension: diagnosis and management.
    Kiely DG; Elliot CA; Sabroe I; Condliffe R
    BMJ; 2013 Apr; 346():f2028. PubMed ID: 23592451
    [No Abstract]   [Full Text] [Related]  

  • 3. Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management.
    Racz H; Mehta S
    J Rheumatol; 2006 Sep; 33(9):1723-5. PubMed ID: 16960934
    [No Abstract]   [Full Text] [Related]  

  • 4. Scleroderma lung disease.
    Le Pavec J; Launay D; Mathai SC; Hassoun PM; Humbert M
    Clin Rev Allergy Immunol; 2011 Apr; 40(2):104-16. PubMed ID: 20063208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma].
    Hunzelmann N; Riemekasten G
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S325-7. PubMed ID: 17139598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
    Sasahara AA
    J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular disease in systemic sclerosis.
    Poredos P
    Vasa; 2011 Jan; 40(1):3-4. PubMed ID: 21375075
    [No Abstract]   [Full Text] [Related]  

  • 8. Borderline pulmonary pressures in scleroderma - a 'pre-pulmonary arterial hypertension' condition?
    Kovacs G; Olschewski H
    Arthritis Res Ther; 2015 May; 17(1):123. PubMed ID: 25981512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and therapy of pulmonary hypertension in systemic sclerosis.
    Bull TM
    Curr Opin Rheumatol; 2007 Nov; 19(6):598-603. PubMed ID: 17917541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and management of scleroderma lung disease.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1999 Nov; 11(6):508-13. PubMed ID: 10551676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.
    Thakkar V; Nikpour M; Stevens WM; Proudman SM
    Intern Med J; 2015 Mar; 45(3):248-54. PubMed ID: 25735576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac complications of systemic sclerosis: recent progress in diagnosis.
    Boueiz A; Mathai SC; Hummers LK; Hassoun PM
    Curr Opin Rheumatol; 2010 Nov; 22(6):696-703. PubMed ID: 20657283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical approach to screening for scleroderma-associated pulmonary arterial hypertension.
    Fischer A; Bull TM; Steen VD
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):303-10. PubMed ID: 22076819
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
    Valenzuela A; Nandagopal S; Steen VD; Chung L
    Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the diagnosis and management of scleroderma-related vascular complications.
    Kerin K; Yost JH
    Compr Ther; 1998; 24(11-12):574-81. PubMed ID: 9847974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension: screening and evaluation in scleroderma.
    York M; Farber HW
    Curr Opin Rheumatol; 2011 Nov; 23(6):536-44. PubMed ID: 21934501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach.
    Robertson L; Pignone A; Kowal-Bielecka O; Fiori G; Denton CP; Matucci-Cerinic M
    Ann Rheum Dis; 2005 Jun; 64(6):804-7. PubMed ID: 15897302
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinico-functional characteristics of pulmonary arterial hypertension in systemic scleroderma].
    Mirrakhimov MM; Moldotashev IK; Bakeeva ME; Shmidt GF
    Ter Arkh; 1994; 66(3):67-71. PubMed ID: 8202858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
    Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
    Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis - a systematic overview: part 1 - disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance.
    Klein-Weigel P; Opitz C; Riemekasten G
    Vasa; 2011 Jan; 40(1):6-19. PubMed ID: 21283969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.